Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.

Created on 24 Jun 2026

Authors

Laura Fabbri, Katerina Antoniou, Torsten Gerriet Blum, Philippe Camus, Aurélie Cazes, Joanna Chorostowska-Wynimko, Pierre Foidart, Georgia Hardavella, Marjolein A Heuvelmans, Theodoros Karampitsakos, Michael Kreuter, Maria Joana Pereira Catarata, Jarushka Naidoo, Antonio Passaro, Solange Peters, Helmut Prosch, Anne-Marie Russell, David Laszlo Tarnoki, Joanna C Porter, Julien Guiot

Published in

ERJ open research. Volume 12. Issue 3. Epub Jun 22, 2026.

Abstract

A standardised risk assessment before initiating ICI treatment may improve early detection and management of IR-ILD. Multidisciplinary collaboration is crucial for enhancing patient safety, improving treatment outcomes and advancing research. https://bit.ly/4qAthl6.

PMID:
42338674
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement